Skip to main content

Table 3 Ovarian reserve markers in patients before and after DHEA treatment

From: Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial

Paremeters

Pre-treatmentn=42

Post-treatmentn=42

P-value

AMH (ng/ml)

1.01 ± 0.77

1.29 ± 1.09

.015

FSH (mIU/mL)

11.68 ± 6.62

9.45 ± 5.09

.036

Estradiol (pg/ml)

186.58 ± 142.19

110.79 ± 68.28

.002

DHEA-S (μg/mL)

1.24 ± 0.74

5.50 ± 3.48

.000

Testosterone(nmol/L)

0.74 ± 0.41

2.25 ± 1.28

.000

Antral follicle count

2.95 ± 1.38

3.21 ± 1.22

.054

  1. Data are presented as mean ± SD (standard deviation). P<.05 was considered as statistically significant.